Meanwhile, miR-25-3p (part of the miR-25 cluster) has been shown to promote malignant phenotypes by also regulating the PTEN/Akt pathway and the promotion of the epithelial–mesenchymal transition similarly, as does miR-92a in non-small-cell lung cancer cells (NSCLC) and miR-129-5p in retinoblastomas by targeting PAX6 [93,94,95]. This evidence concerns the gene PAX6 and non-small cell lung carcinoma.